Notice to the media - Government of Canada to announce support for a Safe Long-term Care Fund (SLTCF) agreement with British Columbia
BURNABY, B.C., Aug. 12, 2021 /CNW/ - The Honourable Harjit Sajjan, Minister of National Defence, on behalf of the Honourable Patty Hajdu, Minister of Health, and Terry Beech, Parliamentary Secretary to the Minister of Fisheries, Oceans and the Canadian Coast Guard and to the Minister of Economic Development and Official Languages (B.C.), will announce support for safe long-term care in British Columbia.
There will be a media availability immediately following the announcement.
Date August 13, 2021
Time 12:30 PM (PDT)
Location
The event will be held in person at:
New Vista Society 7232 New Vista Pl. Burnaby, B.C. V5E 3Z3
Today, RaySearch Laboratories AB (publ) publishes its Annual Report for the financial year 2023. The report is held available on RaySearch's website, under the section Investors.
This information is information that RaySearch Larboratiories AB...
Shareholders of Zinzino AB (publ) are hereby invited to the annual general meeting on Monday, May 27, 2024, at 1:30 PM at the company's premises at Hulda Mellgrens gata 5 in Gothenburg. Registration begins at 1:15 PM.
The company aims to webcast the...
Implantica AG (publ), a med-tech company at the forefront of bringing advanced technology into the body, is publishing its annual report for the fiscal year 2023. The annual report is now available on the company's website.
"Implantica had a very...
Revenue amounted to ?498.8m (?419.3m), an increase of 18.9% with an organic growth of 14.2%.Operating profit (EBIT) was ?19.0m (?10.7m), an increase of 78.0%, representing an operating margin of 3.8% (2.6%).Net profit amounted to ?6.5m (?2.1m), which...
Amwins Global Risks is delighted to announce Classic Cars and Cotswolds, an auction to raise money for the Matthew Wilson Multiple Myeloma Fund at Blood Cancer UK.
The online auction opens today and features Ferraris, Aston Martins, a Rolls Royce, a...
Regulatory News:
Sensorion (FR0012596468 ? ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, today announces...
